OROS hydromorphone of value for osteoarthritis pain

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.543, 2007-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic conditions no longer a pain with OROS hydromorphone

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 504, 2006-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Hydromorphone-OROS formulation

By Goforth Harold W

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1207-1214

Informa Healthcare

Access to resources Recommend Favorite

OROS® Hydromorphone Prolonged Release: A Review of its Use in the Management of Chronic, Moderate to Severe Pain

By Carter Natalie J. Keating Gillian M.

CNS Drugs, Vol. 24, Iss. 4, 2010-04 ,pp. : 337-361

Adis International

Access to resources Recommend Favorite

Use of Hydromorphone, with Particular Reference to the OROS® Formulation, in the Elderly

By Lussier David Richarz Ute

Drugs & Aging, Vol. 27, Iss. 4, 2010-04 ,pp. : 327-335

Adis International

Access to resources Recommend Favorite

OROS hydromorphone vs ER oxycodone: a close call in OA

Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite